PHOENIX, Oct. 6, 2016 /PRNewswire/ -- Lotus Biotechnology Development Corp. (OTCQB: LBTD) a Bionaturals company specializing in the refining of organic materials for the production of powerful detergent and chemical free cleaners, announces that the Company's corporate information and filing requirements has been updated on the OTC Markets website, www.otcmarkets.com, in an effort to fulfill reporting requirements. Presently, the Company's status is reflected as current due to the recent updated filings of the 10K and 10Q.
In light of our commitment to transparency, we believe that keeping OTC current will give us greater visibility, and provide investors with enhanced confidence. We are excited to be moving forward, and intend to keep shareholders fully informed as we continue to reach fundamental milestones," stated Michael Palethorpe, Chief Executive Officer and President, Lotus Biotechnology Development Corp.
The Company recently announced the Grand Opening of the Company's new corporate office in China. In anticipation of the Company's growth strategy, Lotus Biotechnology has established the corporate office in Yong Zhou City to serve as a headquarters for its daily business activity.
About Lotus Biotechnology Development Corp.: Lotus Biotechnology specializes in plant extracting and refining. After years of research and development, the Company has developed the ability to extract tea saponin from Camellia seed and refine it to produce the most natural and organic cleaner. Compared with other chemical cleaners, tea saponin cleaner is more effective in terms of cleaning metal and stainless steel. The new recipe has registered patent in China (Patent Number 210510938973.4) and the product also received approval from China Food and Drug Administration.
For more information please visit: www.lotusbiotechnologies.com
Forward Looking Statements: This news release includes "forward looking statements", as that term is defined in Section 27A of the Unites States Securities Act of 1933, as amended, and Section 21E of the United States Exchange Act of 1934, as amended, that are subject to assumptions, risks and uncertainties. Statements in this news release that are not purely historical are forward looking statements, including without limitation any statements concerning the Company's intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company's future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements.
Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements. Except as required by law, the Company assumes no obligation to update any forward looking statements, whether as a result of new information, future events or otherwise.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lotus-biotechnology-development-corp-fulfills-reporting-requirements-raising-tier-on-otcmarketscom-300340372.html
SOURCE Lotus Biotechnology Development Corp.